 AUSTIN, TX ACCESSWIRE October 12, 2021 Apollo Endosurgery, Inc. Apollo NASDAQ:APEN, a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the pricing of its previously announced underwritten public offering. Apollo is selling 8,400,000 shares of its common stock at a public offering price of 7.75 per share for gross proceeds of approximately 65 million, before deducting underwriting discounts and commissions and offering expenses. 